ImpediMed Limited (ASX:IPD)
0.0340
+0.0010 (3.03%)
Apr 24, 2025, 4:10 PM AEST
ImpediMed Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Net Income | -21.22 | -19.79 | -20.52 | -19.87 | -20.71 | -21.38 | Upgrade
|
Depreciation & Amortization | 1.63 | 0.58 | 0.55 | 1.24 | 0.35 | 0.46 | Upgrade
|
Other Amortization | 1.67 | 1.67 | 1.92 | 1.81 | 1.3 | 0.97 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | 0.05 | - | Upgrade
|
Stock-Based Compensation | -0.68 | -0.68 | 0.75 | 3 | 3.04 | 2.25 | Upgrade
|
Provision & Write-off of Bad Debts | -0.23 | -0.23 | -0.65 | -0.45 | -0.3 | 0.01 | Upgrade
|
Other Operating Activities | -0.14 | -0.02 | 0.33 | 0.4 | 0.64 | 0.35 | Upgrade
|
Change in Accounts Receivable | 1.18 | 1.18 | 0.18 | 0.04 | -0.08 | -0.26 | Upgrade
|
Change in Inventory | 0.05 | 0.05 | 0.12 | -0.55 | 0.49 | 0.26 | Upgrade
|
Change in Accounts Payable | 0.12 | 0.12 | -0.89 | 1.53 | -0.28 | -0.06 | Upgrade
|
Change in Other Net Operating Assets | -0.67 | -0.67 | 0.17 | -2.79 | 2.26 | -1.83 | Upgrade
|
Operating Cash Flow | -18.29 | -17.79 | -18.05 | -15.66 | -13.26 | -19.22 | Upgrade
|
Capital Expenditures | - | -0.08 | -0.39 | -0.06 | -0.07 | -0.09 | Upgrade
|
Sale (Purchase) of Intangibles | -2.02 | -3.02 | -5.65 | -5.16 | -2.39 | -2.07 | Upgrade
|
Investing Cash Flow | -2.02 | -3.11 | -6.04 | -5.22 | -2.46 | -2.16 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 0.17 | - | Upgrade
|
Long-Term Debt Repaid | - | -0.48 | -0.43 | -0.37 | -0.41 | -0.41 | Upgrade
|
Net Debt Issued (Repaid) | -0.46 | -0.48 | -0.43 | -0.37 | -0.24 | -0.41 | Upgrade
|
Issuance of Common Stock | - | 0.06 | 30.02 | 42.5 | 16.84 | 33.25 | Upgrade
|
Other Financing Activities | - | -0.06 | -1.67 | -2.21 | -0.13 | -2.68 | Upgrade
|
Financing Cash Flow | -0.46 | -0.48 | 27.93 | 39.92 | 16.47 | 30.16 | Upgrade
|
Foreign Exchange Rate Adjustments | 1.56 | 0.3 | 1.14 | 2.02 | -0.73 | -0.45 | Upgrade
|
Net Cash Flow | -19.21 | -21.08 | 4.98 | 21.05 | 0.02 | 8.33 | Upgrade
|
Free Cash Flow | -18.29 | -17.87 | -18.44 | -15.72 | -13.32 | -19.31 | Upgrade
|
Free Cash Flow Margin | -158.45% | -173.18% | -162.56% | -148.82% | -158.45% | -336.33% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade
|
Levered Free Cash Flow | -14.22 | -16.44 | -18.95 | -13.31 | -9.13 | -16.67 | Upgrade
|
Unlevered Free Cash Flow | -14.17 | -16.38 | -18.93 | -13.3 | -9.1 | -16.62 | Upgrade
|
Change in Net Working Capital | 1.81 | -0.18 | 1.82 | 0.71 | -3.03 | 2.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.